Form 4 for LQDA Liquidia Corp
Accepted 2026-08-19 18:21:25 ET · period of report 2026-08-17 · accession 0001104659-26-098862 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-19 18:21 | 2026-08-17+ | LQDA | Saggar Rajeev | Chief Medical Off | S - Sale+OE | $75.09 | -79.5K | 142.3K | -36% | -$5.97M |
| D | 2026-08-19 18:21 | 2026-08-19 | LQDA | Saggar Rajeev | Chief Medical Off | M - OptEx | $3.73 | +50.0K | 192.3K | +35% | +$186.5K |
| D | 2026-08-19 18:21 | 2026-08-19 | LQDA | Saggar Rajeev | Chief Medical Off | M - OptEx | $0.00 | -50.0K | 150.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | S | D | 29,534 | $76.84 | 142,265 | D | — | — | (F1) Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $76.76 to $77.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-08-19 | M | A | 50,000 | $3.73 | 192,265 | D | — | — | (F2) Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2026-08-19 | S | D | 50,000 | $74.06 | 142,265 | D | — | — | (F3) Represents the subsequent sale of the underlying shares from the exercise of stock options reported on this Form 4. (F4) Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $74.00 to $74.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-08-19 | M | D | 50,000 | $0.00 | 150,000 | D | $3.73 · 2026-07-18 to 2032-07-18 | 50,000 Common Stock | (F5) The option vested over a four-year period with 25% vesting on July 18, 2023 and the remaining 75% vesting ratably on a monthly basis over three years thereafter and became fully vested on July 18, 2026. |